Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan--a representative population-based comparative study.

Chang YC, Chou YJ, Liu JY, Yeh TF, Huang N.

J Infect. 2012 Sep;65(3):231-8. doi: 10.1016/j.jinf.2012.04.014. Epub 2012 May 3.

PMID:
22561486
2.

Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity.

Christenson B, Pauksen K, Sylvan SP.

Virol J. 2008 Apr 28;5:52. doi: 10.1186/1743-422X-5-52.

3.

Additive preventive effect of influenza and pneumococcal vaccines in elderly persons.

Christenson B, Hedlund J, Lundbergh P, Ortqvist A.

Eur Respir J. 2004 Mar;23(3):363-8.

4.

The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease.

Nichol KL, Baken L, Wuorenma J, Nelson A.

Arch Intern Med. 1999 Nov 8;159(20):2437-42.

PMID:
10665892
5.

Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study.

Mahamat A, Daurès JP, de Wzieres B.

Hum Vaccin Immunother. 2013 Jan;9(1):128-35. doi: 10.4161/hv.22550.

6.

Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up.

Hedlund J, Christenson B, Lundbergh P, Ortqvist A.

Vaccine. 2003 Sep 8;21(25-26):3906-11.

PMID:
12922125
7.

The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.

Tsai YH, Hsieh MJ, Chang CJ, Wen YW, Hu HC, Chao YN, Huang YC, Yang CT, Huang CC.

Vaccine. 2015 Jun 9;33(25):2897-902. doi: 10.1016/j.vaccine.2015.04.068. Epub 2015 Apr 30.

PMID:
25936662
8.
10.

Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria.

Andrews RM, Skull SA, Byrnes GB, Campbell DA, Turner JL, McIntyre PB, Kelly HA.

Commun Dis Intell Q Rep. 2005;29(3):283-8.

11.

Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: a population-based cohort study.

Sung LC, Chen CI, Fang YA, Lai CH, Hsu YP, Cheng TH, Miser JS, Liu JC.

Vaccine. 2014 Jun 24;32(30):3843-9. doi: 10.1016/j.vaccine.2014.04.064. Epub 2014 May 14.

PMID:
24837769
12.

Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States.

Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP.

MBio. 2011 Jan 25;2(1):e00309-10. doi: 10.1128/mBio.00309-10.

13.

Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers.

Gilchrist SA, Nanni A, Levine O.

Am J Public Health. 2012 Apr;102(4):596-605. doi: 10.2105/AJPH.2011.300512. Epub 2012 Feb 16. Review.

14.

Effectiveness of pneumococcal polysaccharide vaccine in older adults.

Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, Hanson CA, Mahoney LD, Shay DK, Thompson WW; Vaccine Safety Datalink.

N Engl J Med. 2003 May 1;348(18):1747-55.

15.

Effectiveness of influenza vaccination in elderly diabetic patients: a retrospective cohort study.

Wang IK, Lin CL, Chang YC, Lin PC, Liang CC, Liu YL, Chang CT, Yen TH, Huang CC, Sung FC.

Vaccine. 2013 Jan 11;31(4):718-24. doi: 10.1016/j.vaccine.2012.11.017. Epub 2012 Nov 12.

PMID:
23153445
16.

The impact of influenza vaccinations on the adverse effects and hospitalization rate in the elderly: a national based study in an Asian country.

Ho TY, Huang KY, Huang TT, Huang YS, Ho HC, Chou P, Lin CH, Wei CK, Lian WC, Chen TC, Huang HB, Lee CC.

PLoS One. 2012;7(11):e50337. doi: 10.1371/journal.pone.0050337. Epub 2012 Nov 28.

17.

Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.

Domínguez A, Castilla J, Godoy P, Delgado-Rodríguez M, Saez M, Soldevila N, Astray J, Mayoral JM, Martín V, Quintana JM, González-Candelas F, Galán JC, Tamames S, Castro A, Baricot M, Garín O, Pumarola T; CIBERESP Cases and Controls in Pandemic Influenza Working Group (Spain).

Hum Vaccin Immunother. 2013 Apr;9(4):865-73. doi: 10.4161/hv.23090. Epub 2013 Apr 1.

18.

Influenza and pneumococcal vaccination of the elderly in Taiwan.

Chen YH, Liou SH, Chou CC, Su WL, Loh CH, Lin SH.

Vaccine. 2004 Jul 29;22(21-22):2806-11.

PMID:
15246615
19.

Influenza and pneumococcal vaccination levels among persons aged > or = 65 years--United States, 1999.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2001 Jun 29;50(25):532-7.

20.

Prevention of mortality and pneumonia among nursing home older adults by dual pneumococcal and seasonal influenza vaccination during a pandemic caused by novel pandemic influenza A (H1N1).

Chan TC, Hung IF, Luk JK, Shea YF, Chan FH, Woo PC, Chu LW.

J Am Med Dir Assoc. 2012 Oct;13(8):698-703. doi: 10.1016/j.jamda.2012.05.009. Epub 2012 Jun 20.

PMID:
22722051
Items per page

Supplemental Content

Write to the Help Desk